SMS Pharmaceuticals Limited (SMSPHARMA) — Announcement | 22 July 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Company sends reminder letters for unclaimed dividends over seven years
💡 Investor Takeaway
Shareholders must claim unpaid dividends by October 25, 2026 or risk their shares being transferred to IEPF without further notice.

SMS Pharmaceuticals Limited announced on July 22, 2026 that it is sending reminder letters to shareholders who have not claimed dividends for seven or more consecutive years, requiring them to claim unpaid dividends by October 25, 2026 or risk compulsory transfer of shares to the Investor Education and Protection Fund (IEPF) as mandated by SEBI LODR Regulation 30 and Section 124(6) of the Companies Act, 2013. The filing details the procedural requirements for claiming dividends and the consequences of non-claim, including KYC compliance and documentation needed for electronic or physical shareholding. This regulatory action ensures compliance with investor protection norms but signals potential share transfers that could affect shareholding structures.

📄 View Original Announcement (PDF)

About SMS Pharmaceuticals Limited (SMSPHARMA)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹3,437.97 Cr P/E: 32.7 ROE: 14.3% ROCE: 15.2% Div Yield: 0.11%

View full SMSPHARMA stock details →

📡 Get AI alerts when SMSPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SMSPHARMA — Free

📊 More SMSPHARMA filings

See all SMSPHARMA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SMSPHARMA files new disclosures

Track SMSPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SMSPHARMA — Free

Free account · 2 AI queries/day